Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2014, Article ID 879749, 8 pages
http://dx.doi.org/10.1155/2014/879749
Clinical Study

A Randomized Prospective Study of Bowel Preparation for Colonoscopy with Low-Dose Sodium Phosphate Tablets versus Polyethylene Glycol Electrolyte Solution

Department of Gastroenterology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

Received 26 June 2014; Revised 15 August 2014; Accepted 4 September 2014; Published 15 September 2014

Academic Editor: Spiros D. Ladas

Copyright © 2014 Erina Kumagai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Altobelli, A. Lattanzi, R. Paduano, G. Varassi, and F. di Orio, “Colorectal cancer prevention in Europe: burden of disease and status of screening programs,” Preventive Medicine C, vol. 62, pp. 132–141, 2014. View at Google Scholar
  2. Cancer Facts and Figure 2014, American Cancer Society, Atlanta, Ga, USA, 2014.
  3. B. K. Edwards, E. Ward, B. A. Kohler et al., “Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates,” Cancer, vol. 116, no. 3, pp. 544–573, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Matsuda, T. Matsuda, A. Shibata, K. Katanoda, T. Sobue, and H. Nishimoto, “Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project,” Japanese Journal of Clinical Oncology, vol. 44, no. 4, Article ID hyu003, pp. 388–396, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Kastenberg, R. Chasen, C. Choudhary et al., “Efficacy and safety of sodium phosphate tablets compared with PEG solution in colon cleansing: Two identically designed, randomized, controlled, parallel group, multicenter phase III trials,” Gastrointestinal Endoscopy, vol. 54, no. 6, pp. 705–713, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. L. C. Hookey and S. Vanner, “A review of current issues underlying colon cleansing before colonoscopy,” Canadian Journal of Gastroenterology, vol. 21, no. 2, pp. 105–111, 2007. View at Google Scholar · View at Scopus
  7. J. F. Johanson, J. W. Popp Jr., L. B. Cohen et al., “A randomized, multicenter study comparing the safety and efficacy of sodium phosphate tablets with 2L polyethylene glycol solution plus bisacodyl tablets for colon cleansing,” The American Journal of Gastroenterology, vol. 102, no. 10, pp. 2238–2246, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Kastenberg, C. Barish, H. Burack et al., “Tolerability and patient acceptance of sodium phosphate tablets compared with 4-L PEG solution in colon cleansing: Combined results of 2 identically designed, randomized, controlled, parallel group, multicenter phase 3 trials,” Journal of Clinical Gastroenterology, vol. 41, no. 1, pp. 54–61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. F. B. Cebesoy, O. Balat, and S. Pence, “SodiumPhosphate (NaP) versus polyethylene glycol-electrolyte lavage solution (PEG-ELS) tolerability: a prospective randomized study in patients with gynecological malignancy,” European Journal of Gynaecological Oncology, vol. 29, no. 2, pp. 162–164, 2008. View at Google Scholar · View at Scopus
  10. S. R. Gurudu, F. Li, D. E. Fleischer et al., “Patient preference and acceptance with sodium phosphate tablet preparation for colonoscopy,” Digestive Diseases and Sciences, vol. 54, no. 7, pp. 1555–1559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. A. Aronchick, W. H. Lipshutz, S. H. Wright, F. Dufrayne, and G. Bergman, “A novel tableted purgative for colonoscopic preparation: efficacy and safety comparisons with Colyte and Fleet Phospho-Soda,” Gastrointestinal Endoscopy, vol. 52, no. 3, pp. 346–352, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Korsten, A. M. Spungen, A. R. Rosman et al., “A prospective assessment of renal impairment after preparation for colonoscopy: oral sodium phosphate appears to be safe in well-hydrated subjects with normal renal status,” Digestive Diseases and Sciences, vol. 55, no. 7, pp. 2021–2029, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Hosoe, M. Nakashita, H. Imaeda et al., “Comparison of patient acceptance of sodium phosphate versus polyethylene glycol plus sodium picosulfate for colon cleansing in Japanese,” Journal of Gastroenterology and Hepatology, vol. 27, no. 10, pp. 1617–1622, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Kambe, Y. Yamaji, T. Sugimoto et al., “A randomized controlled trial of sodium phosphate tablets and polyethylene glycol solution for polyp detection,” Journal of Digestive Diseases, vol. 13, no. 7, pp. 374–380, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. A. Burke and J. M. Church, “Enhancing the quality of colonoscopy: the importance of bowel purgatives,” Gastrointestinal Endoscopy, vol. 66, no. 3, pp. 565–573, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. R. W. Golub, B. A. Kerner, W. E. Wise Jr. et al., “Colonoscopic bowel preparations—which one? A blinded, prospective, randomized trial,” Diseases of the Colon and Rectum, vol. 38, no. 6, pp. 594–599, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Tajika, Y. Niwa, V. Bhatia et al., “Can mosapride citrate reduce the volume of lavage solution for colonoscopy preparation?” World Journal of Gastroenterology, vol. 19, no. 5, pp. 727–735, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Tajika, Y. Niwa, V. Bhatia et al., “Efficacy of mosapride citrate with polyethylene glycol solution for colonoscopy preparation,” World Journal of Gastroenterology, vol. 18, no. 20, pp. 2517–2525, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Belsey, O. Epstein, and D. Heresbach, “Systematic review: adverse event reports for oral sodium phosphate and polyethylene glycol,” Alimentary Pharmacology & Therapeutics, vol. 29, no. 1, pp. 15–28, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Aradhye and J. M. Brensilver, “Sodium phosphate-induced hypernatremia in an elderly patient: a complex pathophysiologic state,” The American Journal of Kidney Diseases, vol. 18, no. 5, pp. 609–611, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Boivin and S. R. Kahn, “Symptomatic hypocalcemia from oral sodium phosphate: a report of two cases,” The American Journal of Gastroenterology, vol. 93, no. 12, pp. 2577–2579, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Vukasin, L. A. Weston, and R. W. Beart, “Oral Fleet Phospho-Soda laxative-induced hyperphosphatemia and hypocalcemic tetany in an adult: report of a case,” Diseases of the Colon and Rectum, vol. 40, no. 4, pp. 497–499, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. E. D. Ehrenpreis, J. J. Nogueras, V. A. Botoman, G. F. Bonner, D. Zaitman, and K. M. Secrest, “Serum electrolyte abnormalities secondary to Fleet's Phospho-Soda colonoscopy prep,” Surgical Endoscopy, vol. 10, no. 10, pp. 1022–1024, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. C. P. Escalante, M. Weiser, and K. Finkel, “Hyperphosphatemia associated with phosphorus-containing laxatives in a patient with chronic renal insufficiency,” Southern Medical Journal, vol. 90, no. 2, pp. 240–242, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. A. J. P. Filho and M. N. Lassman, “Severe hyperphosphatemia induced by a phosphate-containing oral laxative,” Annals of Pharmacotherapy, vol. 30, no. 2, pp. 141–143, 1996. View at Google Scholar · View at Scopus
  26. A. Fine and J. Patterson, “Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: two cases and a review of the literature,” The American Journal of Kidney Diseases, vol. 29, no. 1, pp. 103–105, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Ullah, R. Yeh, and M. Ehrinpreis, “Fatal hyperphosphatemia from a phosphosoda bowel preparation,” Journal of Clinical Gastroenterology, vol. 34, no. 4, pp. 457–458, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. G. S. Markowitz, M. B. Stokes, J. Radhakrishnan, and V. D. D'Agati, “Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure,” Journal of the American Society of Nephrology, vol. 16, no. 11, pp. 3389–3396, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Russmann, L. Lamerato, A. Marfatia et al., “Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol,” The American Journal of Gastroenterology, vol. 102, no. 12, pp. 2655–2663, 2007. View at Publisher · View at Google Scholar · View at Scopus